Skip to menu Skip to content Skip to footer
Dr Eoin O'Sullivan
Dr

Eoin O'Sullivan

Email: 

Overview

Background

Eoin O'Sullivan, MD, PhD is a Consultant Nephrologist (Senior Staff Specialist) at Metro North, and Lecturer at the Institute for Molecular Bioscience, University of Queensland and Associate at QIMR Berghofer. He has a diverse academic background, with degrees in medicine from University College Cork, Ireland , and a PhD from the University of Edinburgh, UK, where he specialized in the biology of senescence in kidney injury. Dr. O'Sullivan also holds multiple certifications in nephrology and a Masters in medical education.

His research focuses on kidney fibrosis and cellular senescence, with over 52 publications and 10 patent applications. His work has been cited more than 15,000 times, and he has contributed to major advancements in therapeutic strategies for chronic kidney disease. He collaborates extensively with industry partners to develop anti-fibrotic therapies, with several of his discoveries leading to potential new drug targets.

In addition to his research, Dr. O'Sullivan is actively involved in medical education and mentorship, involved with ANZSN Educational an scientific comittees, with national level educational experiences both in Australia and in UK.

Current Research focus:

Theme 1. Senescence

Using single cell RNA-Seq techniques to discover therapeutic targets for people living with Kidney Disease.

Theme 2: Translational Data analysis

Machine learning and AI approaches to clinical data interpretation, prognosis, decision support.

Availability

Dr Eoin O'Sullivan is:
Available for supervision

Research interests

  • Senescence

    Understanding cellular senescence as a biomarkers and therapeutic target for chronic disease outcomes, in particular renal fibrosis/CKD

  • single cell RNA-Seq

    novel translational approaches to using single cell RNA-Seq, in particular to uncover targets and biomarkers in CKD

  • Machine learning and AI

    analysis of large volumes of public data ( ECG, clinical parameters, text ) with international collaborations - looking for translational pathways for novel algorithms - in particular focused on Renal and cardiological outcomes,

  • Renal Vasculitis

    translational focus on clinical data, access to patient data, samples, network of collaborators

Research impacts

Complete list of published works: https://orcid.org/0000-0002-7709-6595

My senescence research program to date has created new knowledge in the field of kidney fibrosis and senescence, documented across multiple publications demonstrating international and cross disciplinary reach attracting over 2,500 citations from 74 countries across 6 continents including major institutions such as University of Oxford, Cambridge, Harvard, Mayo clinic, Johns Hopkins, and several Australian universities. My publications are in the top 10% cited worldwide and appear in the top 10% of journals. Research areas citing this work include cellular biology, computational biology, clinical medicine, and pharmacology (Scival 13/1/24). this program alone places me on the 86th citation percentile for researchers (WOS 6/3/23) Several of these papers are in the top 1% of citations for their ESI subject area (Scival)

Works

Search Professor Eoin O'Sullivan’s works on UQ eSpace

41 works between 2014 and 2025

1 - 20 of 41 works

2025

Journal Article

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Abani, O., Abbas, A., Abbas, F., Abbas, J., Abbas, K., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., Abdelqader, B., Abdul, A., Abdul, B., Abdul, S., Abdul Rasheed, A., Abdulakeem, A., Abdul-Kadir, R., Abdullah, A., Abdulmumeen, A., Abdul-Raheem, R., Abdulshukkoor, N., Abdusamad, K., Abed El Khaleq, Y., Abedalla, M., Abeer Ul Amna, A., Abel, L., Abernethy, K. ... Zuriaga-Alvaro, A. (2025). Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81 103080, 103080. doi: 10.1016/j.eclinm.2025.103080

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2024

Journal Article

Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβ

Kiourtis, Christos, Terradas-Terradas, Maria, Gee, Lucy M., May, Stephanie, Georgakopoulou, Anastasia, Collins, Amy L., O’Sullivan, Eoin D., Baird, David P., Hassan, Mohsin, Shaw, Robin, Tan, Ee Hong, Müller, Miryam, Engelmann, Cornelius, Andreola, Fausto, Hsieh, Ya-Ching, Reed, Lee H., Borthwick, Lee A., Nixon, Colin, Clark, William, Hanson, Peter S., Sumpton, David, Mackay, Gillian, Suzuki, Toshiyasu, Najumudeen, Arafath K., Inman, Gareth J., Campbell, Andrew, Barry, Simon T., Quaglia, Alberto, Morris, Christopher M. ... Bird, Thomas G. (2024). Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβ. Nature Cell Biology, 26 (12) eaan1230, 2075-2083. doi: 10.1038/s41556-024-01543-3

Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβ

2024

Journal Article

A comparison of the diagnostic ability of large language models in challenging clinical cases

Khan, Maria Palwasha and O'Sullivan, Eoin Daniel (2024). A comparison of the diagnostic ability of large language models in challenging clinical cases. Frontiers in Artificial Intelligence, 7 1379297, 1379297. doi: 10.3389/frai.2024.1379297

A comparison of the diagnostic ability of large language models in challenging clinical cases

2024

Journal Article

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Faust, Saul N, Haynes, Richard, Jones, Christine E, Staplin, Natalie, Whittaker, Elizabeth, Jaki, Thomas, Juszczak, Ed, Spata, Enti, Wan, Mandy, Bamford, Alasdair, Dimitri, Paul, Finn, Adam, Furness, John, Ramanan, Athimalaipet V, Gale, Christopher, Cathie, Katrina, Drysdale, Simon, Bernatoniene, Jolanta, Murray, Clare, Roehr, Charles C, Fleming, Paul, Riordan, Andrew, Bandi, Srini, Jyothish, Deepthi, Evans, Jennifer, Emonts, Marieke, Kelly, Dominic, Pathan, Nazima, Davies, Patrick ... Zuriaga-Alvaro, A. (2024). Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child and Adolescent Health, 8 (3), 190-200. doi: 10.1016/S2352-4642(23)00316-4

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024

Journal Article

Avacopan as an additional therapeutic intervention to promote renal recovery in severe ANCA-associated vasculitis: A case report

Atrens, Aleks D., Hutton, Holly, O'Sullivan, Eoin, Moore, John and Madhan, Krishan (2024). Avacopan as an additional therapeutic intervention to promote renal recovery in severe ANCA-associated vasculitis: A case report. Nephrology, 29 (2), 105-107. doi: 10.1111/nep.14253

Avacopan as an additional therapeutic intervention to promote renal recovery in severe ANCA-associated vasculitis: A case report

2024

Book Chapter

Nephron Senescence and Mechanisms

Healy, Helen, Kassianos, Andrew J., Ng, Monica S. Y. and O’Sullivan, Eoin D. (2024). Nephron Senescence and Mechanisms. Kidney Disease in the Elderly. (pp. 25-41) Cham, Switzerland: Springer. doi: 10.1007/978-3-031-68460-9_3

Nephron Senescence and Mechanisms

2023

Journal Article

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani, O., Abbas, A., Abbas, F., Abbas, J., Abbas, K., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., Abdelqader, B., Abdul, A., Abdul, B., Abdul, S., Abdul Rasheed, A., Abdulakeem, A., Abdul-Kadir, R., Abdullah, A., Abdulmumeen, A., Abdul-Raheem, R., Abdulshukkoor, N., Abdusamad, K., Abed El Khaleq, Y., Abedalla, M., Abeer Ul Amna, A., Abel, L., Abernethy, K. ... Zuriaga-Alvaro, A. (2023). Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes and Endocrinology, 11 (12), 905-914. doi: 10.1016/S2213-8587(23)00253-X

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023

Journal Article

Do early relapses predict the risk of long-term relapsing disease in an adult and paediatric cohort with MOGAD?

Chen, Bo, Gomez-Figueroa, Enrique, Redenbaugh, Vyanka, Francis, Anna, Satukijchai, Chanjira, Wu, Yan, Messina, Silvia, Sa, Mario, Woodhall, Mark, Robertson, Neil P., Lim, Ming, Wassmer, Evangeline, Kneen, Rachel, Huda, Saif, Blain, Camilla, Halfpenny, Christopher, Hemingway, Cheryl, O'Sullivan, Eoin, Hobart, Jeremy, Fisniku, Leonora K., Martin, Roswell J., Dobson, Ruth, Cooper, Sarah A., Williams, Victoria, Waters, Patrick, Chen, John J., Pittock, Sean J., Ramdas, Sithara, Leite, Maria Isabel ... Palace, Jacqueline (2023). Do early relapses predict the risk of long-term relapsing disease in an adult and paediatric cohort with MOGAD?. Annals of Neurology, 94 (3), 508-517. doi: 10.1002/ana.26731

Do early relapses predict the risk of long-term relapsing disease in an adult and paediatric cohort with MOGAD?

2023

Conference Publication

A family of flare- a case of lupus nephritis associated with SPENDCI syndrome with a sister having similar syndrome

Pagnis, Rachna, Hepburn, Kirsten, O'Sullivan, Eoin and Puri, Priyanka (2023). A family of flare- a case of lupus nephritis associated with SPENDCI syndrome with a sister having similar syndrome. 58th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Christchurch, New Zealand, 4–6 September 2023. Richmond, VIC, Australia: John Wiley & Sons.

A family of flare- a case of lupus nephritis associated with SPENDCI syndrome with a sister having similar syndrome

2023

Conference Publication

Discovery And Validation Of Novel Renal Epithelial Senescence Associated Biomarkers

Baird, David, Reck, Maximilian, Campbell, Ross, O'Sullivan, Eoin, Docherty, Marie-Helena, Cairns, Carolynn, Carvalho, Cyril, Vermeren, Matthieu, Hughes, Jeremy, Mark, Patrick, Denby, Laura, Conway, Bryan, Mylonas, Katie and Ferenbach, David (2023). Discovery And Validation Of Novel Renal Epithelial Senescence Associated Biomarkers. 60th ERA Congress, Milan, Italy, 15-18 June 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfad063c_4455

Discovery And Validation Of Novel Renal Epithelial Senescence Associated Biomarkers

2023

Journal Article

Indian Hedgehog release from TNF-activated renal epithelia drives local and remote organ fibrosis

O'Sullivan, Eoin D., Mylonas, Katie J., Xin, Cuiyan, Baird, David P., Carvalho, Cyril, Docherty, Marie-Helena, Campbell, Ross, Matchett, Kylie P., Waddell, Scott H., Walker, Alexander D., Gallagher, Kevin M., Jia, Siyang, Leung, Steve, Laird, Alexander, Wilflingseder, Julia, Willi, Michaela, Reck, Maximilian, Finnie, Sarah, Pisco, Angela, Gordon-Keylock, Sabrina, Medvinsky, Alexander, Boulter, Luke, Henderson, Neil C., Kirschner, Kristina, Chandra, Tamir, Conway, Bryan R., Hughes, Jeremy, Denby, Laura, Bonventre, Joseph V. and Ferenbach, David A. (2023). Indian Hedgehog release from TNF-activated renal epithelia drives local and remote organ fibrosis. Science Translational Medicine, 15 (698) abn0736, eabn0736. doi: 10.1126/scitranslmed.abn0736

Indian Hedgehog release from TNF-activated renal epithelia drives local and remote organ fibrosis

2022

Journal Article

Single-cell analysis of senescent epithelia reveals targetable mechanisms promoting fibrosis

O'Sullivan, Eoin D., Mylonas, Katie J., Bell, Rachel, Carvalho, Cyril, Baird, David P., Cairns, Carolynn, Gallagher, Kevin M., Campbell, Ross, Docherty, Marie, Laird, Alexander, Henderson, Neil C., Chandra, Tamir, Kirschner, Kristina, Conway, Bryan, Dihazi, Gry H., Zeisberg, Michael, Hughes, Jeremy, Denby, Laura, Dihazi, Hassan and Ferenbach, David A. (2022). Single-cell analysis of senescent epithelia reveals targetable mechanisms promoting fibrosis. JCI Insight, 7 (22) e154124. doi: 10.1172/jci.insight.154124

Single-cell analysis of senescent epithelia reveals targetable mechanisms promoting fibrosis

2022

Journal Article

Cognitive bias is a crucial factor in nurses' decision making

O'sullivan, Eoin D. (2022). Cognitive bias is a crucial factor in nurses' decision making. Evidence-Based Nursing, 26 (1), 37-37. doi: 10.1136/ebnurs-2022-103585

Cognitive bias is a crucial factor in nurses' decision making

2022

Journal Article

Covid-19: the government's gaslighting has left vulnerable patients feeling forgotten

O'Sullivan, Eoin D. (2022). Covid-19: the government's gaslighting has left vulnerable patients feeling forgotten. The BMJ (378) o2033. doi: 10.1136/bmj.o2033

Covid-19: the government's gaslighting has left vulnerable patients feeling forgotten

2022

Journal Article

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani, Obbina, Abbas, Ali, Abbas, Fatima, Abbas, Mustafa, Abbasi, Sadia, Abbass, Hakam, Abbott, Alfie, Abdallah, Nabeel, Abdelaziz, Ashraf, Abdelfattah, Mohamed, Abdelqader, Bushra, Abdul, Basir, Abdul Rasheed, Althaf, Abdulakeem, Ajibode, Abdul-Kadir, Rezan, Abdullah, Abdullah, Abdulmumeen, Abdulfatahi, Abdul-Raheem, Rasheed, Abdulshukkoor, Niyaz, Abdusamad, Kula, Abed El Khaleq, Yazeed, Abedalla, Mai, Ul-Amna, Abeer, Abernethy, Katrina, Aboaba, Adebanke, Abo-Leyah, Hani, Abou-Haggar, Ahmed, Abouibrahim, Mahmoud, Abraham, Miriam ... RECOVERY Collaborative Group (2022). Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325), 665-676. doi: 10.1016/S0140-6736(22)00163-5

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2022

Journal Article

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani, Obbina, Abbas, Ali, Abbas, Fatima, Abbas, Mustafa, Abbasi, Sadia, Abbass, Hakam, Abbott, Alfie, Abdallah, Nabeel, Abdelaziz, Ashraf, Abdelfattah, Mohamed, Abdelqader, Bushra, Abdul, Basir, Abdul Rasheed, Althaf, Abdulakeem, Ajibode, Abdul-Kadir, Rezan, Abdullah, Abdullah, Abdulmumeen, Abdulfatahi, Abdul-Raheem, Rasheed, Abdulshukkoor, Niyaz, Abdusamad, Kula, Abed El Khaleq, Yazeed, Abedalla, Mai, Abeer Ul Amna, Abeer Ul Amna, Abernethy, Katrina, Aboaba, Adebanke, Abo-Leyah, Hani, Abou-Haggar, Ahmed, Abouibrahim, Mahmoud, Abraham, Miriam ... RECOVERY Collaborative Group (2022). Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10320), 143-151. doi: 10.1016/S0140-6736(21)01825-0

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021

Journal Article

Aging modulates the effects of ischemic injury upon mesenchymal cells within the renal interstitium and microvasculature

Shaw, Isaac W., O'Sullivan, Eoin D., Pisco, Angela O., Borthwick, Gary, Gallagher, Kevin M., Péault, Bruno, Hughes, Jeremy and Ferenbach, David A. (2021). Aging modulates the effects of ischemic injury upon mesenchymal cells within the renal interstitium and microvasculature. Stem Cells Translational Medicine, 10 (8), 1232-1248. doi: 10.1002/sctm.20-0392

Aging modulates the effects of ischemic injury upon mesenchymal cells within the renal interstitium and microvasculature

2021

Journal Article

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Abani, Obbina, Abbas, Ali, Abbas, Fatima, Abbas, Mustafa, Abbasi, Sadia, Abbass, Hakam, Abbott, Alfie, Abdallah, Nabeel, Abdelaziz, Ashraf, Abdelfattah, Mohamed, Abdelqader, Bushra, Abdo, David, Abdul, Basir, Abdul Rasheed, Althaf, Abdulakeem, Ajibode, Abdul-Kadir, Rezan, Abdulle, Amina, Abdulmumeen, Abdulfatahi, Abdul-Raheem, Rasheed, Abdulshukkoor, Niyaz, Abdusamad, Kula, Abed El Khaleq, Yazeed, Abedalla, Mai, Abeer Ul Amna, Abeer Ul Amna, Abernethy, Katrina, Aboaba, Adebanke, Abo-Leyah, Hani, Abou-Haggar, Ahmed, Abouibrahim, Mahmoud ... RECOVERY Collaborative Group (2021). Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289), 2049-2059. doi: 10.1016/S0140-6736(21)00897-7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

2021

Journal Article

Cellular senescence inhibits renal regeneration after injury in mice, with senolytic treatment promoting repair

Mylonas, Katie J., O’Sullivan, Eoin D., Humphries, Duncan, Baird, David P., Docherty, Marie-Helena, Neely, Sarah A., Krimpenfort, Paul J., Melk, Anette, Schmitt, Roland, Ferreira-Gonzalez, Sofia, Forbes, Stuart J., Hughes, Jeremy and Ferenbach, David A. (2021). Cellular senescence inhibits renal regeneration after injury in mice, with senolytic treatment promoting repair. Science Translational Medicine, 13 (594) eabb0203. doi: 10.1126/scitranslmed.abb0203

Cellular senescence inhibits renal regeneration after injury in mice, with senolytic treatment promoting repair

2021

Journal Article

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani, Obbina, Abbas, Ali, Abbas, Fatima, Abbas, Mustafa, Abbasi, Sadia, Abbass, Hakam, Abbott, Alfie, Abdallah, Nabeel, Abdelaziz, Ashraf, Abdelfattah, Mohamed, Abdelqader, Bushra, Abdul, Basir, Abdul Rasheed, Althaf, Abdulakeem, Ajibode, Abdul-Kadir, Rezan, Abdulmumeen, Abdulfatahi, Abdul-Raheem, Rasheed, Abdulshukkoor, Niyaz, Abdusamad, Kula, Abed El Khaleq, Yazeed, Abedalla, Mai, Abeer Ul Amna, Abeer, Abernethy, Katrina, Aboaba, Adebanke, Abo-Leyah, Hani, Abou-Haggar, Ahmed, Abouibrahim, Mahmoud, Abraham, Miriam, Abraham, Tizzy ... RECOVERY Collaborative Group (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285), 1637-1645. doi: 10.1016/S0140-6736(21)00676-0

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Supervision

Availability

Dr Eoin O'Sullivan is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Media

Enquiries

For media enquiries about Dr Eoin O'Sullivan's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au